Genome Editors Begin Lining Up for Inscripta®’s Onyx® Platform
The first of the fully automated benchtop instruments, designed to enable genome editing at unprecedented scale, will go to Jef...
Read More
Inscripta® pushes funding to $260 million as they launch genome editing platform
Inscripta presentations can begin with the advent of agriculture. Or even further back: The emergence of man.
Read More
Serial Biotech Entrepreneur Kevin Ness Has Raised $260 Million To Get His Genome-Engineering Device Into The Hands Of Every Scientist Who Wants One
Kevin Ness has made a career of building tools for biologists. Now, with the burgeoning field of synthetic biology booming,...
Read More
$125 million for Inscripta® may usher in the next wave of genetic engineering
In these waning days of the second decade of the twenty-first century, technologists and investors are beginning to lay the...
Read More
Biotech Investors Clamor for Crispr-Focused Tech in Surprise Round
Inscripta Inc. wasn’t seeking to raise capital when the genome-engineering company presented for the first time publicly at SynBioBeta, the…
Read More
How Inscripta®’s Onyx® platform is making creativity the biologist’s only limiting factor
As technology improves and our capabilities increase, biology is moving from gene-scale to genome-scale, think one gene at a time...
Read More
Genomics Going from a Passive to an Active Science: John Stuelpnagel on the “Write” Revolution
“I think the next level of biological discovery is going to be where you can actively perturb the system — it’s called...
Read More
Omics Tools Firms See Opportunities in Burgeoning Synthetic Biology Industry
And it’s the application of biology at “scale.” This concept was embodied by the headline sponsor, Inscripta, which debuted its...
Read More
A first-timer’s take on SynBioBeta2019: We can actually build — and are building — a better world
“It didn’t take long for that extraordinary evidence to arrive. The first Keynote speaker of the conference, Inscripta’s Kevin Ness,...
Read More
Technology stands out at synthetic biology conference
“Inscripta, based in Boulder, Colorado, debuted a benchtop machine for CRISPR gene editing during SynBioBeta. The machine is designed to edit…
Read More